Nitya Nair

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi et al. · Clinical Cancer Research · 2021 · 362 citations · Full text

Medicine, Oncology, Pharmacology +15

Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization

Evan W. Newell, Natalia Sigal, Nitya Nair et al. · Nature Biotechnology · 2013 · 303 citations

Life Sciences, Immunology, Molecular Biology +11

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Funda Meric‐Bernstam, Randy F. Sweis, Stefan Kasper et al. · Clinical Cancer Research · 2022 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.

Funda Meric‐Bernstam, Shahneen Sandhu, Omid Hamid et al. · Journal of Clinical Oncology · 2019 · 192 citations

Life Sciences, Immunology, Oncology +17

Clinical Response of Live-Attenuated, <i>Listeria monocytogenes</i> Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma

Raffit Hassan, Evan Alley, Hedy L. Kindler et al. · Clinical Cancer Research · 2019 · 127 citations · Full text

Medicine, Cancer Biology, Oncology +11